CBS 2019
CBSMD教育中心
English

肺动脉高压

科研文章

荐读文献

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Treatment Effects of Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Stratified by REVEAL Risk Score: Results from PADN-CFDA Trial Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes Haemodynamic definitions and updated clinical classification of pulmonary hypertension
|<< 1 2 3 4 5 6 7 8 >>|

Original Research2013 Sep 17;62(12):1092-1100.

JOURNAL：J Am Coll Cardiol. Article Link

Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension)

Chen SL, Zhang FF, Xu J et al. Keywords: 6-min walk test; 6MWT; CO; IPAH; MPA; N-terminal brain natriuretic peptide; NT-BNP; PA; PADN; PAH; PAOP; PAP; PVR; RA; RV; TPG; Tei; cardiac output; denervation; idiopathic pulmonary arterial hypertension; main pulmonary artery; pulmonary artery; pulmonary artery denervation; pulmonary artery hypertension; pulmonary artery occlusive pressure; pulmonary artery pressure; pulmonary vascular resistance; right atrium/atrial; right ventricle/ventricular; transpulmonary pressure gradient; tricuspid excursion index

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top